• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Vitamins and Dietary Supplements in Belgium Product Image

Vitamins and Dietary Supplements in Belgium

  • Published: August 2013
  • Region: Europe, Belgium
  • 50 Pages
  • Euromonitor International

FEATURED COMPANIES

  • Arkopharma NV SA
  • Biodiphar NV SA
  • Centrapharm NV SA
  • Madaus Pharma NV SA
  • Omega Pharma SA
  • Sanofi-Synthélabo NV
  • MORE

Whilst opinions differed on the fortunes of vitamins and dietary supplements in 2011, industry consensus was that the whole category was in a state of crisis in 2012. From 14 December 2012, the regulatory environment for vitamins and dietary supplements was set to become stricter, with new regulation of health claims. Thus, during the whole of 2012, players were on the home straight in terms of conforming to the new EFSA (European Food Safety Authority) regulation. In addition, trade sources...

The Vitamins and Dietary Supplements in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Product coverage: Dietary Supplements, Paediatric Vitamins and Dietary Supplements, Tonics and Bottled Nutritive Drinks, Vitamins.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Vitamins and Dietary Supplements market;
- Pinpoint growth sectors and READ MORE >

VITAMINS AND DIETARY SUPPLEMENTS IN BELGIUM

August 2013

LIST OF CONTENTS AND TABLES

Headlines
Trends
Vitamins
Dietary Supplements
Competitive Landscape
Prospects
Category Data
Summary 1 Dietary Supplements: Brand Ranking by Positioning 2012
Table 1 Sales of Vitamins and Dietary Supplements by Category: Value 2007-2012
Table 2 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2007-2012
Table 3 Multivitamin by Positioning 2007-2012
Table 4 Dietary Supplements by Positioning 2007-2012
Table 5 Vitamins and Dietary Supplements Company Shares by Value 2008-2012
Table 6 Vitamins and Dietary Supplements Brand Shares by Value 2009-2012
Table 7 Vitamins Brand Shares by Value 2009-2012
Table 8 Dietary Supplements Brand Shares by Value 2009-2012
Table 9 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2012-2017
Table 10 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2012-2017
Laboratoires Pharmaceutiques Trenker SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 2 Laboratoires Pharmaceutiques Trenker SA: Key Facts
Summary 3 Laboratoires Pharmaceutiques Trenker SA: Operational Indicators
Company Background and Production
Competitive Positioning
Summary 4 Laboratoires Pharmaceutiques Trenker SA: Competitive Position 2012
Laboratoria Qualiphar NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 5 Laboratoria Qualiphar NV SA: Key Facts
Summary 6 Laboratoria Qualiphar NV SA: Operational Indicators
Company Background and Production
Competitive Positioning
Summary 7 Laboratoria Qualiphar NV SA: Competitive Position 2012
Tilman NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 8 Tilman NV SA: Key Facts
Summary 9 Tilman NV SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 Tilman NV SA: Competitive Position 2012
Executive Summary
2012 Is Not A Good Year for Consumer Health
More Repressive Juridical Context Than Deregulation
Multinationals Are the Most Affected
Distribution Remains Under the Control of Chemists/pharmacies, Despite Some Changes
Bleak Prospects Overall
Key Trends and Developments
the Outlook Is Clouding Over for Consumer Health
Health and Wellness Called To Order
Local Authorities and Experts Do Not Help Matters
Urgent Need for Calm
Local Environment Leaves More Limited Room for Manoeuvre for Multinationals
Market Indicators
Table 11 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 12 Life Expectancy at Birth 2007-2012
Market Data
Table 13 Sales of Consumer Health by Category: Value 2007-2012
Table 14 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 15 Consumer Health Company Shares 2008-2012
Table 16 Consumer Health Brand Shares 2009-2012
Table 17 Penetration of Private Label by Category 2007-2012
Table 18 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 19 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 20 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Generics
Switches
Summary 11 OTC: Switches 2010-2012
Sources
Summary 12 Research Sources

Slightly better growth expected
After two years of non-negligible growth, OTC healthcare might perform better up to 2010 than during the historic period thanks to the diminishing effects of government policy, the development of more segmented and convenient products and the ageing population.

Analgesics, cough, cold and allergy remedies, digestive remedies and even medicated skin care will enjoy modest but positive growth despite the expected upsurge of private label products. Deregulated dietary supplements will remain the strongest growth driver thanks to manufacturer creativity in developing products to match the rising demand for preventive treatments and functional substances.

Companies Mentioned Include:
- Janssen-Cilag NV
- Synthélabo Belgium SA
- Boehringer Ingelheim NV SA
- Novartis Consumer Health SA NV
- Roche NV SA
- Omega Pharma SA
- Procter & Gamble Eurocor NV SA
- Merck Sharp & Dohme BV
- Pfizer Consumer Healthcare NV SA
- Boots Healthcare NV
- Glaxo Wellcome Belgium NV
- UPSA Médica NV SA
- Aventis Pharma NV SA
- Zambon NV SA
- Bayer NV SA
- Beiersdorf NV SA
- Ricola AG
- Menarini Benelux
- Viatris GmbH & Co KG
- Norgine NV SA
- Laboratoria Qualiphar NV SA
- Sanofi-Synthélabo NV
- Biodiphar NV SA
- Centrapharm NV SA
- Will Pharma NV SA
- Bio-Fyt Pharma NV
- Whitehall Benelux SA
- Arkopharma NV SA
- Fournier Pharma NV SA
- Biodynamics NV
- Ortis, Laboratoires
- Madaus Pharma NV SA

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos